NKGen Biotech, Inc. Common Stock (NKGN) stock news · $22.4M cap
NKGen Biotech, Inc. Common Stock (NKGN) is a biotechnology company listed on US.
This NKGN news page leads with what NKGen Biotech, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for NKGN yet. We will not pad this page with generic market recap.
Latest reported NKGN revenue for 2023-12-31 was $0. Net income was -$83.0M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. NKGN currently screens at market cap $22.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NKGN stock page; for the tape open the quote page.
Not investment advice.